<DOC>
	<DOC>NCT00959439</DOC>
	<brief_summary>The purpose of this study is to demonstrate the relative bioavailability of Naproxen delayed-release tablets (375 mg).</brief_summary>
	<brief_title>Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Positive test results for HIV or hepatitis B or C. Treatment for drug or alcohol dependence.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>